Crossmark

Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial

Crossref DOI link: https://doi.org/10.1007/s12602-021-09858-5

Published Online: 2021-10-13

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ivashkin, Vladimir

Fomin, Victor

Moiseev, Sergey

Brovko, Michail

Maslennikov, Roman https://orcid.org/0000-0001-7513-1636
Ulyanin, Anatoly

Sholomova, Victoria

Vasilyeva, Maria

Trush, Elizaveta

Shifrin, Oleg

Poluektova, Elena
License Information

Text and Data Mining valid from 2021-10-13

Version of Record valid from 2021-10-13
More Information

Article History

Accepted: 5 October 2021

First Online: 13 October 2021

Declarations

:

: The study was approved by the local ethics committee (Conclusion №. 34-20 of September 9, 2020) in accordance with the Declaration of Helsinki.

: Informed consent was obtained from all individual participants included in the study.

: Patients’ personal data are not published.

: The authors declare no competing interests.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below